J&J says proposed opioid settlement to lower reported third quarter profit by $3 billion

(Reuters) - Johnson & Johnson on Wednesday lowered its previously reported profit for the third quarter to $1.8 billion (£1.40 billion) from $4.8 billion to account for a proposed opioid settlement payment.The company lowered its earnings per share for the quarter to $0.66 from $1.81, and said there was no impact to its adjusted earnings numbers.A framework deal, announced on Monday, was hammered out by some companies and attorneys general in North Carolina, Pennsylvania, Tennessee and Texas,..